HFS
FUSN

Heritage Financial Services’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Heritage Financial Services’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$2K – 535
2022
Q2 		$2K Buy
+1,000
New +$4.59K ﹤0.01% 429

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Heritage Financial Services's FUSN Position: Q3 2022 in Review

Heritage Financial Services sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q3 2022, closing a stake of 1,000 shares — an estimated $2K sold.

Heritage Financial Services first reported a position in FUSN in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 34 funds tracked by Wall St. Rank hold FUSN as of Q3 2022.

  • Heritage Financial Services reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q3 2022 after selling out during the quarter.
  • Heritage Financial Services sold 1,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q3 2022, an estimated $2K.
  • Heritage Financial Services first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2022 and held it in 1 quarter.
  • Heritage Financial Services's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2022.

Based on Heritage Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.